|
|
|
0 studies |
0.00% |
|
|
"OMIC" technologies |
1 study |
0.07% |
|
|
Disaster risk reduction and health emergencies |
1 study |
0.07% |
|
|
|
0 studies |
0.00% |
|
|
"OMIC" technologies |
2 studies |
0.15% |
|
|
Biomedical products and engineering |
4 studies |
0.30% |
|
|
Communicable diseases |
1 study |
0.07% |
|
|
Diagnostics |
40 studies |
2.95% |
|
|
Drug discovery and development |
32 studies |
2.36% |
|
|
Emerging and re-emerging diseases |
1 study |
0.07% |
|
|
Functional foods |
2 studies |
0.15% |
|
|
Genomics/Molecular Technology |
1 study |
0.07% |
|
|
Health information systems |
1 study |
0.07% |
|
|
Information and communication technologies for health |
6 studies |
0.44% |
|
Global competitiveness and innovation in health |
Information and communication technology (ICT) for health |
1 study |
0.07% |
|
|
Accidents and injuries |
1 study |
0.07% |
|
|
Disaster risk reduction and health emergencies |
4 studies |
0.30% |
|
|
Emerging and re-emerging diseases |
5 studies |
0.37% |
|
|
Environmental threats to health |
1 study |
0.07% |
|
Health resiliency |
Occupational health and migration |
1 study |
0.07% |
|
|
Health human resources |
1 study |
0.07% |
|
|
Improving Access to Quality Hospitals and Health Care Facilities |
2 studies |
0.15% |
|
Health Service Delivery |
Improving Provision of Public Health Services |
1 study |
0.07% |
|
Health Technology Development |
Diagnostics |
2 studies |
0.15% |
|
|
|
0 studies |
0.00% |
